FINWIRES · TerminalLIVE
FINWIRES

歐洲、中東和非洲地區石油市場最新消息:霍爾木茲海峽對峙加劇,原油價格飆升至每桶100美元以上

-- 週四,原油期貨價格重回每桶100美元上方,創下兩週新高,因為美伊外交努力破裂。 布蘭特原油期貨合約上漲1.3%,至每桶103.25美元。穆爾班原油4月22日收在每桶103.12美元,截至發稿時已停止交易。 盛寶銀行分析師表示:“布倫特原油期貨週三結算價高於每桶101美元,上漲3.5%至每桶101.91美元,創兩週新高。此前有報道稱,美伊計劃重新安排和平談判,但最終未能實現。” 專家表示,伊朗在霍爾木茲海峽扣押兩艘油輪,以及五角大廈估計可能需要六個月才能清除該水道的水雷,目前市場正在積極調整價格,以應對可能持續的供應危機。 根據路透社週三報道,美軍在亞洲水域攔截了至少三艘懸掛伊朗國旗的船隻,並將它們從各自位置驅離,局勢進一步升級。 伊朗議會議長穆罕默德·巴格爾·加利巴夫在X電視台表示,只要美國繼續實施海上封鎖,重新開放霍爾木茲海峽就“不可能”,這加劇了僵局感。他稱美國的封鎖是「劫持世界經濟」。 隨著布蘭特原油價格強勢回升至每桶100美元上方,荷蘭國際集團(ING)和盛寶銀行(Saxo Bank)的分析師警告稱,市場對外交方面的噪音已經“麻木”,轉而準備應對長期的實際中斷。 然而,此次價格飆升正在引發需求驟減,尤其是在歐洲。 Rystad分析師報告稱,歐洲煉油商目前正面臨利潤率暴跌和原油供應趨緊的雙重困境,由於波斯灣原油供應仍受到嚴重限制,這兩種因素疊加很可能迫使燃料產量下降。 由於目前尚無解決方案,儘管高昂的成本開始抑制全球消費,但業內人士仍預期油價將進一步上漲。

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB